全文获取类型
收费全文 | 100997篇 |
免费 | 6153篇 |
国内免费 | 437篇 |
专业分类
耳鼻咽喉 | 1135篇 |
儿科学 | 2527篇 |
妇产科学 | 1803篇 |
基础医学 | 12511篇 |
口腔科学 | 1754篇 |
临床医学 | 10695篇 |
内科学 | 20286篇 |
皮肤病学 | 1340篇 |
神经病学 | 10110篇 |
特种医学 | 3906篇 |
外国民族医学 | 3篇 |
外科学 | 16400篇 |
综合类 | 1093篇 |
一般理论 | 131篇 |
预防医学 | 8315篇 |
眼科学 | 2085篇 |
药学 | 6495篇 |
中国医学 | 107篇 |
肿瘤学 | 6891篇 |
出版年
2023年 | 565篇 |
2022年 | 936篇 |
2021年 | 2096篇 |
2020年 | 1326篇 |
2019年 | 2098篇 |
2018年 | 2550篇 |
2017年 | 1827篇 |
2016年 | 1992篇 |
2015年 | 2281篇 |
2014年 | 3452篇 |
2013年 | 4743篇 |
2012年 | 7574篇 |
2011年 | 7995篇 |
2010年 | 4590篇 |
2009年 | 4135篇 |
2008年 | 7164篇 |
2007年 | 7474篇 |
2006年 | 7189篇 |
2005年 | 6910篇 |
2004年 | 6737篇 |
2003年 | 6063篇 |
2002年 | 5718篇 |
2001年 | 845篇 |
2000年 | 557篇 |
1999年 | 894篇 |
1998年 | 1223篇 |
1997年 | 926篇 |
1996年 | 755篇 |
1995年 | 685篇 |
1994年 | 592篇 |
1993年 | 579篇 |
1992年 | 446篇 |
1991年 | 403篇 |
1990年 | 334篇 |
1989年 | 298篇 |
1988年 | 282篇 |
1987年 | 281篇 |
1986年 | 245篇 |
1985年 | 285篇 |
1984年 | 308篇 |
1983年 | 255篇 |
1982年 | 333篇 |
1981年 | 283篇 |
1980年 | 225篇 |
1979年 | 96篇 |
1978年 | 128篇 |
1977年 | 108篇 |
1976年 | 84篇 |
1975年 | 69篇 |
1973年 | 75篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
992.
Jonathan G. Amatruda MD Ronit Katz DPhil Carmen A. Peralta MD MAS Michelle M. Estrella MD MHS Harini Sarathy MBBS MHS Linda F. Fried MD MPH Anne B. Newman MD MPH Chirag R. Parikh MBBS PhD Joachim H. Ix MD MAS Mark J. Sarnak MD MS Michael G. Shlipak MD MPH for the Health ABC Study 《Journal of the American Geriatrics Society》2021,69(3):726-734
993.
994.
995.
996.
Helen Sawaya Kevin Johnson Matthew Schmidt Ashley Arana George Chahine Mia Atoui David Pincus Mark S. George Jaak Panksepp Ziad Nahas 《The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)》2015,18(6)
Background:
Major depressive disorder has been associated with abnormal resting-state functional connectivity (FC), especially in cognitive processing and emotional regulation networks. Although studies have found abnormal FC in regions of the default mode network (DMN), no study has investigated the FC of specific regions within the anterior DMN based on cytoarchitectonic subdivisions of the antero-medial pre-frontal cortex (PFC). Studies from different areas in the field have shown regions within the anterior DMN to be involved in emotional intelligence. Although abnormalities in this region have been observed in depression, the relationship between the ventromedial PFC (vmPFC) function and emotional intelligence has yet to be investigated in depressed individuals.Methods:
Twenty-one medication-free, non–treatment resistant, depressed patients and 21 healthy controls underwent a resting state functional magnetic resonance imaging session. The participants also completed an ability-based measure of emotional intelligence: the Mayer-Salovey-Caruso Emotional Intelligence Test. FC maps of Brodmann areas (BA) 25, 10m, 10r, and 10p were created and compared between the two groups.Results:
Mixed-effects analyses showed that the more anterior seeds encompassed larger areas of the DMN. Compared to healthy controls, depressed patients had significantly lower connectivity between BA10p and the right insula and between BA25 and the perigenual anterior cingulate cortex. Exploratory analyses showed an association between vmPFC connectivity and emotional intelligence.Conclusions:
These results suggest that individuals with depression have reduced FC between antero-medial PFC regions and regions involved in emotional regulation compared to control subjects. Moreover, vmPFC functional connectivity appears linked to emotional intelligence. 相似文献997.
Mark J. Niciu David A. Luckenbaugh Dawn F. Ionescu Erica M. Richards Jennifer L. Vande Voort Elizabeth D. Ballard Nancy E. Brutsche Maura L. Furey Carlos A. Zarate Jr 《The international journal of neuropsychopharmacology / official scientific journal of the Collegium Internationale Neuropsychopharmacologicum (CINP)》2015,18(1)
Background:
A single subanesthetic infusion of the N-methyl-D-aspartate (NMDA) receptor antagonist ketamine has rapid and potent antidepressant properties in treatment-resistant major depressive disorder (TRD). As a family history of an alcohol use disorder is a positive predictor of ketamine’s antidepressant response and the strength of the association increases over time, we hypothesized that depressed subjects with a family history of an alcohol use disorder would have greater antidepressant durability and that riluzole would augment and/or extend ketamine’s antidepressant efficacy.Methods:
Fifty-two TRD subjects received an open-label infusion of ketamine (0.5mg/kg over 40 minutes), and, four to six hours post-infusion, were randomized to either flexible-dose (100–200mg/day) riluzole or placebo in the following proportions: Family History Positive (FHP) riluzole (n = 10), FHP placebo (n = 9), Family History Negative (FHN) riluzole (n = 16), and FHN placebo (n = 17).Results:
FHP subjects randomized to placebo had a greater antidepressant response than FHN subjects; however, contrary to our initial hypothesis, there was no significant difference in antidepressant efficacy with riluzole. Although potentially underpowered, there was no difference in overall time-to-relapse based on randomization status (riluzole responders: n = 15, placebo responders: n = 17). Yet, time-to-relapse was longer in FHP placebo responders (n = 8) compared to FHN placebo responders (n = 9) with, again, no significant difference in time-to-relapse in FHP riluzole responders (n = 6) compared to FHN riluzole responders (n = 9).Conclusions:
Ketamine’s extended antidepressant durability in FHP TRD should be considered in the design and analysis of ketamine depression trials. 相似文献998.
999.
Jeffrey J. Talbot Dominador Calamba Melody Pai Mark Ma Theingi M. Thway 《The AAPS journal》2015,17(6):1446-1454
Decisions about efficacy and safety of therapeutic proteins (TP) designed to target soluble ligands are made in part by their ex vivo quantification. Ligand binding assays (LBAs) are critical tools in measuring serum TP levels in pharmacokinetic, toxicokinetic, and pharmacodynamic studies. This study evaluated the impact of reagent antibody affinities, assay incubation times, and analytical platform on free or total TP quantitation. An ELISA-based LBA that measures monoclonal anti-sclerostin antibody (TPx) was used as the model system. To determine whether the method measures free or total TPx, the effects of Kon, Koff, and KD were determined. An 8:1 molar ratio of sclerostin (Scl) to TPx compared to a 1:1 molar ratio produced by rabbit polyclonal antibodies to TPx was required to achieve IC50, a measure of TPx interference effectiveness, making it unclear whether the ELISA truly measured free TPx. Kinetic analysis revealed that Scl had a rapid dissociation rate (Koff) from TPx and that capture and detection antibodies had significantly higher binding affinities (KD) to TPx. These kinetic limitations along with long ELISA incubation times lead to the higher molar ratios (8:1) required for achieving 50% inhibition of TPx. However, a microfluidic platform with the same reagent pairs required shorter incubations to achieve a lower Scl IC50 molar ratio (1:1). The findings from this study provide the bioanalytical community with a deeper understanding of how reagent and platform selection for LBAs can affect what a particular method measures, either free or total TP concentrations.KEY WORDS: affinity and kinetics, association and dissociation, free versus total, interference, ligand binding assay 相似文献
1000.